Archives for January 30, 2007

← 2007

Coley to outsource future drug discovery

By  Kirsty Barnes

After having to abandon a promising experimental hepatitis C vaccine and shedding over a fifth of its workforce, Coley Pharmaceutical has announced it will look to outsource future drug discovery.

Verona Pharma picks UK firm for outsourcing

By  Emilie Reymond

UK biotech company Verona Pharma has contracted fellow UK firm Onyx to manufacture supplies of its new hay fever drug candidate for forthcoming preclinical and clinical studies.

Lentigen enters disposables market to cut production time

By  Susan Gotensparre

Viral vector manufacturer Lentigen has entered into a collaboration with Wave Biotech to gain access to disposable process and equipment expertise, which ties in with a shift in the bioprocess manufacturing sector towards using disposable systems.

Covance in good health

By  Kirsty Barnes

Covance has again reported a healthy business performance with a 6.4 per cent increase in sales of $343m (€266m) for the fourth quarter of 2006.

Adderall drives pharma division at Johnson Matthey

By  Susan Gotensparre

Johnson Matthey has announced a reassuring business update ahead of its 31 March year-end, suggesting that Adderall is the driving force behind a recovery in its pharmaceutical materials business.

Xcellerex receives $20m boost for disposable manufacturing tech

By  Anna Lewcock

US-based firm Xcellerex yesterday announced it has completed the second half of a $20m (€15.4m) financing deal, raising $11m to speed up commercialisation of its innovative disposable manufacturing technology for vaccines and biotherapeutics.